Objectives-To describe the frequency and characteristics of those patients initially registered with the Scottish Motor Neuron Disease Register (SMNDR) but who subsequently had a diagnosis other than MND made (false positives), to analyse the features which led to a revised diagnosis, and to draw conclusions which might improve routine neurological practice. Methods-The Scottish Motor Neuron Disease Register is a community based, prospective disease register to identify and follow up all incident cases of motor neuron disease in Scotland. Fifty three patients out of a total of 552 registered are presented, who, after initial registration, were later excluded because they failed to satisfy the register's diagnostic criteria. Results-Seven of these patients were labelled as "MND plus" syndromes and may represent a distinct subset of MND. The remaining 46 patients had an alternative diagnosis made (false positive group), accounting for 8% of the total. In half of these cases, potentially beneficial therapies are available. The predominant reasons which lead to a diagnostic revision were: failure of symptom progression, development of atypical clinical features for MND, and investigation results. Conclusions-Patients with MND should undergo thorough and relevant investigations at presentation with the emphasis on neuroradiological imaging and neurophysiology; all patients should be followed up by an experienced neurologist, particularly those in whom symptoms and signs are restricted to either the bulbar or spinal muscles; failure of symptom progression or development of atypical features should lead to an early reassessment; finally, patients should be informed of the diagnosis only when it is secure.
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Keywords: motor neuron disease; amyotrophic lateral sclerosis; epidemiology; diagnosis An accurate diagnosis is an essential component of the art of medicine; it enables doctors to make decisions concerning subsequent management and, most importantly from a patient perspective, provides prognostic information. Diseases with either a pathognomic appearance or a definitive investigation result should be the most straightforward to diagnose although abnormal variants may pose difficulties. Unfortunately, neurological practice has few definitive investigations and the clinical appearances may be difficult to precisely categorise into specific disease syndromes. Motor neuron disease (MND) presenting with a classic history and signs, supported by consistent neurophysiology, should rarely cause the experienced neurologist diagnostic doubt. However, many patients present less obviously and patients with other diagnoses may seem to have the features of MND. Yet an accurate and perhaps early diagnosis of MND is crucial for three reasons. Firstly, the appalling prognosis is of the utmost importance to both the patient and their carers (overall 50% survival from symptom onset for our patients was 2-5 years).' Secondly, potentially treatable diseases that mimic MND, such as cervical spondylotic myelopathy or multifocal motor neuropathy, must be identified to allow appropriate therapy. Thirdly, although no effective treatment for MND currently exists, one recent therapeutic trial reported encouraging results.2 Further trials are inevitable and it will be important to correctly diagnose MND early to identify suitable patients for inclusion in randomised trials. If these trials provide convincing evidence for a specific treatment, an early and accurate diagnosis will become even more important for all patients with MND.
The purpose of this paper is to describe the frequency and characteristics of those patients initially registered with the Scottish Motor Neuron Disease Register (SMNDR) but who subsequently had a diagnosis other than MND made (false positives), to analyse the features which led to a revised diagnosis, and to draw conclusions which might improve routine neurological practice.
Methods
The SMNDR was established in January 1989 with the aim of studying the incidence, distribution, clinical features, and prognosis of MND in Scotland, and as a resource for other research. The methods of the study are described in detail elsewhere.34 Briefly, all incident cases (patients in whom a diagnosis of MND was first made after January 1989) of possible, probable, or definite MND in Scotland were identified and then followed up at six monthly intervals via their general practitioner until either death or an alternative diagnosis was made. 
Results
A total of 552 potential incident cases for the period January 1989 to December 1992 were registered. Six of these patients were subsequently deleted from the database as they turned out to be prevalent cases of MND. A further 53 (10%) were excluded as "not MND" and are the subjects of this report. Thirty six (68%) were men, median age 64-5 (range 36-84) years. The sources of first referral were a collaborator (39), SHIPS (six), general practitioner mailshot (five), self referral (two), and mortality data (one). Only seven of these 53 patients were never seen by a neurologist; six of them were registered by a collaborator, either a neurophysiologist or a physician, with a special interest in MND.
At the time of registration 34 (64%) patients had a suggested alternative diagnosis. The regions involved at registration were the bulb only in two patients (4%), limbs only in 38 patients (72%), and both regions in 11 patients (21 %); in two patients the regions involved were uncertain. Table 1 shows the revised diagnoses. In seven patients a diagnosis of "MND plus" was made; these patients had clinical features compatible with MND but also displayed additional abnormalities which led to their exclusion; these were dementia (three), cerebellar disturbance (two), parkinsonism (one), and retinitis pigmentosa with slowed nerve conduction velocities (one); in none of these Fifteen patients (28%) are known to have died (this is likely to be an underestimate as follow up stopped once an alternative diagnosis was reached). Of these, five had necropsies, including detailed neuropathological examinations. Table 2 shows the results. Both patients with a premorbid diagnosis of peripheral neuropathy had undergone neurophysiological testing; in patient 4 this showed evidence of neuronal loss restricted to the C8/T1 level. This was confirmed at necropsy but no cause was identified; he had continued to weaken before death but there do not seem to have been any symptoms related to his lymphoma. Case 5 had widespread neurophysiological evidence of motor neuronal loss which was suggestive but not diagnostic of MND; on his final admission he had not progressed neurologically and a history of alcohol misuse was obtained for the first time. He died suddenly of ischaemic heart disease; although the peripheral nervous system was not examined, there was no evidence of MND in the brain or spinal cord.
We analysed the factors which led to a diagnostic revision and found that there were three predominant reasons, shown in table 1. A failure to progress (and even recovery) was the commonest, prompting reassessment in almost 50%. The development of atypical features (for MND) and the results of investigations were the primary reasons in the remaining patients; radiological imaging and neurophysiology led to a revised diagnosis in equal numbers of patients.
Discussion
Seven patients were labelled as "MND plus" syndromes-that is, in addition to a clinical syndrome compatible with MND, they had features which led to their exclusion according to the SMNDR's diagnostic criteria. This distinction may seem arbitrary and it has been suggested that these patients may represent a continuum of MND, particularly those with associated dementia.67 The neuropathological data from three of the patients seem to support this notion; although only one displayed the characteristic frontal lobe changes previously described,6 all three had the typical pathological appearances of MND. Careful review of the case notes of the remaining four patients, all of whom were cared for by a neurologist, showed that in each case the diagnosis was considered to be MND in addition to the extra features, rather than a unifying diagnosis such as multiple system atrophy. In all four of the patients with multiple system atrophy the diagnosis was made by a neurologist; the additional features were extrapyramidal in three, cerebellar in three, and sphincteric in one. Three had upper motor neuron and lower motor neuron signs, the other purely upper motor neuron signs; three had undergone neurophysiological tests and the results were considered compatible with MND. It is reasonable to question whether these patients should not simply be included in the "MND plus" group but the clinicians clearly thought that the upper and lower motor neuron signs in these four patients were part of a multisystem degeneration; this difference may simply reflect nosological differences between neurologists. However, it seems that the seven "MND plus" patients are better categorised as a distinct subset of MND rather than false positive diagnoses. Excluding these seven patients reduces the proportion of false positive diagnoses to 8%.
Do our results accurately reflect the frequency of the problem? The number of false positives (the numerator) pertains mainly to patients with whom a neurologist was involved. Only seven patients never saw a neurologist at any point in their illness (although six underwent neurophysiological tests). The diagnoses in these patients were normal pressure hydrocephalus with a sensorimotor neuropathy of unknown cause, retropharyngeal tumour, cervical meningioma, cervical spondylotic myelopathy, peripheral neuropathy of unknown cause, and two patients in whom the diagnosis was uncertain. We did not register patients identified by SHIPS, mortality data, self referrals, or as a result of the general practitioner mailshot in whom, although the diagnosis was considered correct by the clinicians involved, perusal of hospital and/or general practitioners' notes disclosed features clearly incompatible with MND; none of these patients had been seen by a neurologist and few had undergone relevant investigations. Hence our results cannot be attributed to misdiagnoses by non-specialists. Because of the design of the register we are confident that the denominator is as complete as possible. Thus we think that 8% is an accurate reflection of the frequency of false positive diagnoses for MND in specialist practice, at least in Scotland.
Were all the false positives definite misdiagnoses? We deliberately encouraged collaborators to register patients as early as possible, regardless of whether they thought that the diagnosis of MND was possible, probable, or definite. Clearly the point at which an individual collaborator registered a patient varied considerably but a high proportion (64%) of the false positive group had an alternative diagnosis suggested at the time of registration; also only three patients fulfilled the criteria for definite MND (upper and lower motor neuron signs in the bulb and one or more spinal regions) at the time of registration. This suggests that many of the cases were not definite misdiagnoses but rather that MND was part of a differential diagnosis; however, in 15 out of 46 (33%) patients the diagnosis of MND was considered secure enough to allow the clinician to inform the patient. As might be expected, the revised diagnoses were, with one or two exceptions, well recognised mimics of MND. It should be noted that potential treatments, either surgical or medical, are available for about half of the non-MND patients, underlining the importance of an accurate diagnosis.
Can we be sure that all these patients definitely did not have MND and how reliable are the alternative diagnoses? Although the decision to exclude a patient from the register and cease further follow up was made by ourselves, we were dependent on the information received from the collaborator or general practitioner caring for the patient. Therefore, the exclusions were all based on the clinical impressions of the responsible physicians, who were usually neurologists; we did not have specific diagnostic criteria for these alternative diagnoses (indeed for many of them, no universally accepted criteria exist). In a few patients, the alternative diagnosis was established histologically (for example, cervical meningioma) and some patients spontaneously improved; clearly these patients definitely did not have MND. But could some of the other diagnoses (for example, cervical spondylotic myeloradiculopathy) have been incorrect and how convincing was the evidence? Of the 10 cases of cervical spondylotic myeloradiculopathy, a neurologist was involved in the care of nine and eight had radiological imaging which their neurologist thought was compatible with cervical spondylotic myeloradiculopathy (the remaining patients improved spontaneously and hence were not imaged Many neurologists only feel completely secure with a diagnosis of MND when upper and lower motor neuron involvement is shown in both the bulbar and spinal regions, either clinically or by neurophysiology. This is borne out by our study; only 11 (21%) patients in the false positive group had bulbar and spinal involvement at registration and only three of these were thought to have definite upper and lower motor neuron lesions in both regions.
In conclusion, a false positive diagnosis of MND by neurologists is uncommon; however, because of the prognostic implications of a diagnosis of MND, it is an important problem. From the results of our study we suggest the following:
(1) All suspected cases of MND require thorough initial investigation to exclude alternative diseases, with neurophysiology and radiological imaging the most important modalities.
(2) All patients should be followed up wherever practical, particularly those in whom upper 
